|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | |
| A61K 9/20 | |||
| A61K 31/551 | |||
| A61P 31/18 |
| (11) | Number of the document | 1646369 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04763093.4 |
| Date of filing the European patent application | 2004-07-05 | |
| (97) | Date of publication of the European application | 2006-04-19 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2004/007309 |
| Date | 2004-07-05 |
| (87) | Number | WO 2005/004836 |
| Date | 2005-01-20 |
| (30) | Number | Date | Country code |
| 486600 P | 2003-07-11 | US | |
| 568204 P | 2004-05-05 | US |
| (72) |
ALBANO, Antonio, A., US
INFELD, Martin, Howard, US
PHUAPRADIT, Wantanee, US
SHAH, Navnit-Hargovindas, US
ZHANG, Lin, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | SAQUINAVIR MESYLATE ORAL DOSAGE FORM |
| SAQUINAVIR MESYLATE ORAL DOSAGE FORM |